Department of Radiology, Ewha Womans Mokdong Hospital, Ewha Womans University School of Medicine, Seoul, Korea.
Department of Radiology and Research Institute of Radiology, University of Ulsan College of Medicine, Asan Medical Center, 88 Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea.
Eur Radiol. 2024 Jan;34(1):538-547. doi: 10.1007/s00330-023-10024-4. Epub 2023 Aug 4.
To investigate the technical feasibility, safety, and efficacy of a long-covered biliary stent in patients with malignant duodenobiliary stricture.
This retrospective study enrolled 57 consecutive patients (34 men, 23 women; mean age, 64 years; range, 32-85 years) who presented with malignant duodenobiliary stricture between February 2019 and November 2020. All patients were treated with a long (18 or 23 cm)-covered biliary stent.
The biliary stent deployment was technically successful in all 57 patients. The overall adverse event rate was 17.5% (10 of 57 patients). Successful internal drainage was achieved in 55 (96.5%) of 57 patients. The median patient survival and stent patency times were 99 days (95% confidence interval [CI], 58-140 days) and 73 days (95% CI, 60-86 days), respectively. Fourteen (25.5%) of the fifty-five patients presented with biliary stent dysfunction due to sludge (n = 11), tumor overgrowth (n = 1), collapse of the long biliary stent by a subsequently inserted additional duodenal stent (n = 1), or rapidly progressed duodenal cancer (n = 1). A univariate Cox proportional hazards model did not reveal any independent predictor of biliary stent patency.
Percutaneous insertion of a subsequent biliary stent was technically feasible after duodenal stent insertion. Percutaneous insertion of a long-covered biliary stent was safe and effective in patients with malignant duodenobiliary stricture.
In patients with malignant duodenobiliary stricture, percutaneous insertion of a long-covered biliary stent was safe and effective regardless of duodenal stent placement.
• Percutaneous insertion of long-covered biliary stents in patients with malignant duodenobiliary stricture is a safe and effective procedure. • Biliary stent deployment was technically successful in all 57 patients and successful internal drainage was achieved in 55 (96.5%) of 57 patients. • The median patient survival and stent patency times were 99 days and 73 days, respectively, after placement of a long-covered biliary stent in patients with duodenobiliary stricture.
探讨长覆膜胆道支架治疗恶性十二指肠胆道狭窄的技术可行性、安全性和疗效。
本回顾性研究纳入 2019 年 2 月至 2020 年 11 月期间 57 例(男 34 例,女 23 例;平均年龄 64 岁;范围 32-85 岁)因恶性十二指肠胆道狭窄就诊的连续患者。所有患者均接受长(18 或 23 cm)覆膜胆道支架治疗。
57 例患者支架置入技术均成功。总不良事件发生率为 17.5%(57 例患者中有 10 例)。57 例患者中 55 例(96.5%)获得了成功的内引流。中位患者生存时间和支架通畅时间分别为 99 天(95%置信区间[CI],58-140 天)和 73 天(95%CI,60-86 天)。55 例成功引流的患者中,14 例(25.5%)因胆泥(n=11)、肿瘤过度生长(n=1)、随后插入的额外十二指肠支架导致长胆道支架塌陷(n=1)或快速进展的十二指肠癌(n=1)而出现胆道支架功能障碍。单因素 Cox 比例风险模型未发现支架通畅的独立预测因素。
十二指肠支架置入后,经皮插入后续胆道支架在技术上是可行的。经皮插入长覆膜胆道支架治疗恶性十二指肠胆道狭窄是安全有效的。
在恶性十二指肠胆道狭窄患者中,经皮插入长覆膜胆道支架是安全有效的,与十二指肠支架的放置无关。
在恶性十二指肠胆道狭窄患者中,经皮插入长覆膜胆道支架是一种安全有效的方法。
57 例患者中,支架置入技术均成功,57 例患者中 55 例(96.5%)获得了成功的内引流。
十二指肠胆道狭窄患者放置长覆膜胆道支架后,患者的中位生存时间和支架通畅时间分别为 99 天和 73 天。